SIBO: Symptoms, Root Causes, and the Functional Medicine Treatment That Actually Works

5 days ago
12 min read

Updated: 2 days ago

You have tried the low FODMAP diet. You cut gluten, then dairy, then onions and garlic. Your bloating improved slightly for a few weeks — and then returned, sometimes worse than before. You feel distended by early afternoon regardless of what you eat, your energy is unreliable, and your concentration isn't what it was. You have been told it is IBS, stress, or simply how your gut works. In my clinical practice, this pattern has a name — and it is one of the most misdiagnosed and undertreated conditions in functional gastroenterology: Small Intestinal Bacterial Overgrowth, or SIBO.

In this article:** - What SIBO is and why it is so frequently misdiagnosed - The three subtypes and why subtype identification changes everything - The five root causes driving SIBO — including one most practitioners miss - Why antibiotics alone produce a 40–44% recurrence rate - The functional medicine approach: testing, herbal antimicrobials, prokinetics, and gut restoration - How I work with SIBO in clinical practice, step by step

What Is SIBO?

SIBO is a condition in which bacteria — in numbers and types that should not be present — colonise the small intestine. Under healthy conditions, the small intestine maintains a relatively low bacterial count (fewer than 10³ organisms per millilitre). When bacterial populations rise significantly, or when colonic bacteria migrate upward into the small bowel, the result is a chronic state of fermentation, inflammation, and malabsorption (Quigley, 2017, *Current Opinion in Gastroenterology*).

There are three recognised subtypes, each with a distinct clinical profile:

Hydrogen-dominant SIBO: associated with diarrhoea, urgent bowel movements, and rapid intestinal transit
Methane-dominant SIBO (IMO — Intestinal Methanogen Overgrowth): associated with constipation, slow transit, and bloating that worsens throughout the day
Hydrogen sulphide SIBO: less commonly tested; associated with sulphur-smelling gas, loose stools, and significant fatigue

Clinical note: Understanding which subtype is present is not academic — it directly determines the antimicrobial protocol, dietary support strategy, and prokinetic selection. Treating SIBO without subtype confirmation is one of the most common reasons treatment fails.*

How Common Is SIBO?

SIBO is significantly more prevalent than most patients — or their GPs — realise. Studies using breath testing estimate that SIBO is present in 6–15% of healthy individuals, rising to 30–85% of patients with IBS, depending on the population and diagnostic criteria used (Takakura & Pimentel, 2020, *Frontiers in Psychiatry*).

Given that IBS affects approximately 10–15% of the global population, the scale of undiagnosed SIBO is considerable. In clinical practice, the vast majority of clients I see with longstanding gut symptoms — particularly those who have followed restrictive diets without lasting relief — test positive for either hydrogen or methane SIBO.

What is frequently missed: the diet did not fail them. It was addressing the consequences of SIBO, not the cause.*

The Root Causes of SIBO

SIBO is not a disease of the gut in isolation. It is a downstream consequence of disrupted gut physiology — most commonly, impaired gut motility and compromised host defence mechanisms. Identifying and addressing root causes is why functional medicine produces more durable results than repeated antibiotic courses.

1. Migrating Motor Complex (MMC) Dysfunction

The migrating motor complex is the gut's housekeeper — a wave of muscular contractions that sweeps residual bacteria, undigested food particles, and cellular debris from the small intestine into the colon during fasting periods. When the MMC is impaired, bacterial populations accumulate in the small bowel rather than being cleared.

MMC dysfunction is the most common upstream cause of SIBO. It is triggered by:

Chronic psychological stress (via the gut-brain axis)
Prior gastrointestinal infection
Thyroid dysfunction and diabetic neuropathy
Long-term use of proton pump inhibitors (PPIs)

This is why SIBO recurs so consistently when treatment does not address motility (Sachdev & Pimentel, 2013, *Therapeutic Advances in Chronic Disease*).

2. Post-Infectious Autoimmunity

Research from Dr Mark Pimentel's laboratory identified a specific autoimmune mechanism underlying a significant proportion of SIBO cases. Following acute gastroenteritis — particularly *Campylobacter jejuni* infection — the immune system produces antibodies against vinculin, a structural protein critical to MMC function. These antibodies cross-react with gut nerve cells, permanently impairing motility and creating conditions for bacterial overgrowth (Pimentel et al., 2015, *Digestive Diseases and Sciences*).

Clinical note: If your gut problems began or worsened after a significant stomach bug, food poisoning, or traveller's diarrhoea — post-infectious dysmotility should always be considered.*

3. Low Stomach Acid (Hypochlorhydria)

Gastric acid is one of the body's primary defences against bacterial overpopulation of the digestive tract. When stomach acid is chronically low — through long-term PPI use, chronic stress, H. pylori infection, or age-related decline — this defence fails, and bacteria reach the small bowel in higher numbers.

Low stomach acid also impairs the absorption of vitamin B12, iron, zinc, and magnesium — deficiencies that compound the nutritional consequences of SIBO itself (Sachdev & Pimentel, 2013).

4. Ileocecal Valve Dysfunction

The ileocecal valve separates the small intestine from the large intestine and prevents the backflow of colonic bacteria into the small bowel. When this valve becomes chronically compromised — through intestinal inflammation, adhesions from previous surgery, or structural dysfunction — colonic bacteria migrate upward into an environment that cannot support them without producing significant fermentation and inflammation.

5. Chronic Stress and HPA Axis Dysregulation

Stress does not merely worsen SIBO symptoms — it creates the conditions for SIBO to develop and persist. Chronic sympathetic nervous system activation directly:

Inhibits MMC function
Reduces stomach acid production
Alters gut microbiome composition
Increases intestinal permeability

In high-functioning clients with demanding careers, SIBO that is successfully treated with antimicrobials recurs rapidly if the stress physiology driving gut dysmotility is not addressed. Nervous system regulation is not an optional add-on — it is a prerequisite for lasting resolution.

Symptoms of SIBO

SIBO produces a wide and often confusing range of symptoms, which explains why it is so frequently misattributed to IBS, stress, or food intolerance:

Bloating: the most consistent symptom; often progressive throughout the day, frequently described as "looking pregnant" by afternoon
Abdominal distension and discomfort: particularly after eating carbohydrate-rich meals
Altered bowel habits: diarrhoea (hydrogen-dominant), constipation (methane-dominant), or alternating patterns
Excessive flatulence: sometimes with a sulphur odour in hydrogen sulphide cases
Fatigue: disproportionate to sleep quality, resulting from systemic inflammation and nutrient malabsorption
Brain fog: impaired concentration and cognitive clarity, particularly post-meal
Nutrient deficiency symptoms: low B12, iron deficiency anaemia, low vitamin D, fat-soluble vitamin deficiency

What is frequently missed: SIBO can present without prominent digestive symptoms. Fatigue, brain fog, skin issues, and joint pain — with minimal bloating — can be the primary presentation, particularly in methane-dominant cases.*

The Conventional Approach and Its Limitations

The standard medical treatment for SIBO is antibiotic therapy:

Rifaximin (Xifaxan): the preferred treatment for hydrogen-dominant SIBO; a non-absorbed antibiotic that acts locally in the gut
Rifaximin combined with Neomycin or Metronidazole: combination therapy for methane-dominant SIBO (IMO)

Rifaximin is well-tolerated and reasonably effective in the short term, with eradication rates of approximately 50–70% (Rezaie et al., 2017, *American Journal of Gastroenterology*). However, recurrence rates are high — studies report SIBO recurrence in 40–44% of patients within 9 months of successful antibiotic treatment — when the root cause is not addressed (Lauritano et al., 2008, *American Journal of Gastroenterology*).

The problem is not the antibiotic. The problem is that antibiotics clear bacteria but do not restore MMC function, correct stomach acid insufficiency, address autoimmune dysmotility, or regulate the nervous system. Without addressing these, the gut environment remains conducive to overgrowth.*

The Functional Medicine Approach to SIBO

Accurate Testing Before Treatment

Effective SIBO management begins with confirmation of diagnosis and subtype identification. I recommend lactulose breath testing as the primary diagnostic tool — it tests the entire small intestine, not just the proximal portion assessed by glucose breath testing. Results are always interpreted alongside clinical presentation, as false negatives occur.

The subtype identified through testing directly determines every subsequent clinical decision.

Herbal Antimicrobial Protocols

Herbal antimicrobials are an evidence-based alternative — or complement — to rifaximin, with a pivotal 2014 study demonstrating equivalent efficacy to rifaximin for hydrogen-dominant SIBO (Chedid et al., 2014, *Global Advances in Health and Medicine*).

Evidence-based options used in clinical practice include:

Berberine: broad-spectrum antimicrobial activity; also supports blood sugar regulation
Oregano oil: active compound carvacrol with demonstrated antimicrobial properties
Allicin (stabilised from garlic): particularly effective for methane-dominant and hydrogen sulphide SIBO
Neem and berberine combinations: used for recurrent or complex presentations

The specific antimicrobial combination and duration of treatment are determined by the individual's SIBO subtype, clinical presentation, and functional lab results — there is no standard template.

Prokinetic Therapy — The Missing Step

Prokinetics stimulate the MMC between meals. Without this, the conditions that allowed SIBO to develop remain intact after antimicrobial treatment — which is the primary reason for relapse.

Evidence-based prokinetic options include:

Ginger root extract: stimulates gastric motility and MMC activity
5-HTP: serotonin precursor; 95% of serotonin is produced in the gut and regulates intestinal motility
Low-dose naltrexone (LDN): prescription-only; modulates gut immune function and supports MMC activity in complex cases

Prokinetic selection and timing are highly individual and always guided by clinical assessment.

Dietary Support During Treatment

Dietary modification during SIBO treatment reduces the fermentable substrate available to bacteria, decreasing gas production and symptom burden during the antimicrobial phase. The specific approach varies by SIBO subtype, symptom pattern, nutritional status, and history of restriction.

What is consistent across all presentations: dietary intervention supports treatment — it is not the treatment. Long-term restrictive diets without addressing the underlying cause consistently worsen outcomes by reducing microbiome diversity. The goal is always to restore dietary breadth, not narrow it permanently.

Because dietary strategy in SIBO is one of the most individually variable aspects of management, I do not apply a fixed template in clinical practice.

Addressing Nutritional Deficiencies

SIBO impairs absorption of multiple critical nutrients through bacterial competition and mucosal damage. I assess the following through functional lab testing before making any recommendations:

Vitamin B12: bacteria consume B12 before it can be absorbed; deficiency causes fatigue, neuropathy, and cognitive impairment
Iron: bacterial fermentation interferes with iron absorption; serum ferritin (not just haemoglobin) is the relevant marker
Vitamin D: fat malabsorption in SIBO impairs absorption of fat-soluble vitamins; status must be tested before supplementing
Magnesium: frequently depleted by dysbiosis and chronic stress
Zinc: essential for gut lining integrity and immune function

Supplementation form, dose, and timing are determined individually based on lab results and clinical presentation. Self-prescribing supplements for SIBO without understanding the underlying subtype and deficiency pattern is rarely effective and can sometimes be counterproductive.*

⚠ When to Seek Medical Investigation

Consult your GP or gastroenterologist promptly if you experience any of the following:

Blood in stool or rectal bleeding
Unexplained weight loss of more than 5% body weight over 6 months
Symptoms that consistently wake you from sleep
Progressive difficulty swallowing
A family history of colorectal cancer or inflammatory bowel disease
Gut symptoms that began after age 50 without prior history

SIBO can coexist with other conditions including Crohn's disease, coeliac disease, and intestinal dysmotility disorders. Ruling out structural pathology through appropriate investigation is always the appropriate first step.

How I Work with SIBO in Clinical Practice

SIBO requires a phased, layered approach — not a single protocol applied uniformly. Here is the structure I follow:

Step 1 — Diagnosis and Root Cause Mapping

Lactulose breath testing, full functional intake, medication and supplement history, stress load assessment. I identify the SIBO subtype, the probable upstream driver (motility, acid, autoimmunity, structural), and nutritional deficiencies requiring immediate support.

*Why this step matters: most SIBO treatment failures begin here — treating without a confirmed subtype and clear root cause.*

Step 2 — Nervous System Regulation

Before beginning antimicrobial treatment, I spend 2–4 weeks on autonomic nervous system regulation. A body in chronic sympathetic activation has impaired gut motility — the very mechanism that allows SIBO to recur.

*Why this step matters: this is the step most practitioners skip, and the most common reason treatment doesn't hold.*

Step 3 — Antimicrobial Phase

Herbal antimicrobials selected and dosed according to subtype, combined with personalised dietary support and prokinetic therapy initiated from the second week. Every aspect of this phase is built around the individual's specific presentation.

*Why this step matters: subtype-matched treatment produces significantly better eradication rates than standard rifaximin alone.*

Step 4 — Gut Restoration

Following antimicrobial treatment, the focus shifts to rebuilding microbiome diversity, repairing intestinal permeability, and restoring nutritional status identified as deficient in the initial assessment.

*Why this step matters: eradication without restoration leaves the gut vulnerable to recolonisation.*

Step 5 — Long-Term Maintenance

Prokinetic support continued as needed. Dietary diversity systematically rebuilt. Nervous system regulation maintained as an ongoing practice. Breath testing repeated to confirm eradication.

*Why this step matters: sustainable resolution requires addressing the root cause — not just repeating the treatment when symptoms return.*

Realistic timeline: significant symptom improvement within 4–8 weeks of antimicrobial treatment. Full gut restoration: 4–6 months.

Frequently Asked Questions

What are the most common symptoms of SIBO?

The most consistent symptom is bloating that worsens progressively through the day, often most severe by afternoon or evening. Associated symptoms include abdominal distension after eating, altered bowel habits, excessive flatulence, fatigue, brain fog, and — in long-standing cases — nutrient deficiency symptoms including low iron, B12, and vitamin D.

Can SIBO cause fatigue and brain fog?

Yes. SIBO-associated fatigue and cognitive impairment have two primary mechanisms: systemic inflammation from bacterial toxins crossing a compromised intestinal barrier, and malabsorption of nutrients essential for energy production and neurological function — particularly B12, iron, and magnesium. In my clinical experience, brain fog that doesn't respond to diet or sleep improvement is frequently a SIBO presentation.

How is SIBO diagnosed?

The most widely used clinical test is the lactulose breath test — a non-invasive test that measures hydrogen and methane gas produced by small intestinal bacteria after ingesting a lactulose solution. Results must be interpreted alongside clinical symptoms and history. The glucose breath test is an alternative but only assesses the proximal small intestine. Aspirate culture (the gold standard) is rarely used in clinical practice due to its invasive nature.

Does the low FODMAP diet cure SIBO?

No. The low FODMAP diet reduces fermentable substrate available to bacteria, which significantly reduces symptoms. It does not eradicate the bacteria. Used long-term without antimicrobial intervention, it can reduce gut microbiome diversity and worsen the underlying environment. It is a support tool for the antimicrobial phase — not a standalone treatment.

Why does SIBO keep coming back?

Recurrence is the defining challenge of SIBO management. The most common reason is failure to address the upstream root cause — typically impaired MMC function, low stomach acid, or chronic stress-driven gut dysmotility. Antibiotics clear bacteria but do not restore the physiological conditions that prevent re-colonisation. Prokinetic therapy, stress regulation, and addressing the specific driver of dysmotility are essential to preventing relapse.

Can SIBO cause weight gain or difficulty losing weight?

Yes, particularly methane-dominant SIBO. Methane gas produced by intestinal methanogens slows intestinal transit, increases caloric extraction from food, and is associated with higher BMI in population studies. Clients with methane SIBO often report feeling unable to lose weight despite eating well — which is, in part, a direct metabolic consequence of the methane-producing organisms themselves.

Are there natural treatments for SIBO that work?

Herbal antimicrobials — particularly berberine, oregano oil, and allicin — are supported by clinical evidence and demonstrated equivalent efficacy to rifaximin in a peer-reviewed study. They are not "natural alternatives" to real medicine — they are active antimicrobial compounds with a strong evidence base. They are best used under clinical guidance, as incorrect selection or subtype mismatch reduces efficacy.

How long does SIBO treatment take?

The antimicrobial phase typically runs 4–6 weeks. Full gut restoration takes a further 2–4 months. Sustained resolution requires ongoing prokinetic support and addressing root cause drivers. Patients who commit to a structured, phased protocol consistently achieve lasting results.

Scientific References

Takakura W, Pimentel M. (2020). Small Intestinal Bacterial Overgrowth and Irritable Bowel Syndrome — An Update. *Frontiers in Psychiatry*, 11, 664. https://doi.org/10.3389/fpsyt.2020.00664
Quigley EMM. (2017). Small intestinal bacterial overgrowth: what it is and what it is not. *Current Opinion in Gastroenterology*, 33(2), 108–112. https://doi.org/10.1097/MOG.0000000000000348
Rezaie A, Buresi M, Lembo A, et al. (2017). Hydrogen and Methane-Based Breath Testing in Gastrointestinal Disorders: The North American Consensus. *American Journal of Gastroenterology*, 112(5), 775–784. https://doi.org/10.1038/ajg.2017.46
Sachdev AH, Pimentel M. (2013). Gastrointestinal bacterial overgrowth: pathogenesis and clinical significance. *Therapeutic Advances in Chronic Disease*, 4(5), 223–231. https://doi.org/10.1177/2040622313496126
Lauritano EC, Gabrielli M, Scarpellini E, et al. (2008). Small intestinal bacterial overgrowth recurrence after antibiotic therapy. *American Journal of Gastroenterology*, 103(8), 2031–2035. https://doi.org/10.1111/j.1572-0241.2008.02030.x
Chedid V, Dhalla S, Clarke JO, et al. (2014). Herbal therapy is equivalent to rifaximin for the treatment of small intestinal bacterial overgrowth. *Global Advances in Health and Medicine*, 3(3), 16–24. https://doi.org/10.7453/gahmj.2014.019
Pimentel M, Morales W, Pokkunuri V, et al. (2015). Autoimmunity Links Vinculin to the Pathophysiology of Chronic Functional Bowel Changes Following Campylobacter jejuni Infection in a Rat Model. *Digestive Diseases and Sciences*, 60(5), 1195–1205. https://doi.org/10.1007/s10620-014-3435-5
Pimentel M, Chow EJ, Lin HC. (2003). Normalization of lactulose breath testing correlates with symptom improvement in irritable bowel syndrome. *American Journal of Gastroenterology*, 98(2), 412–419. https://doi.org/10.1111/j.1572-0241.2003.07234.x
Leventogiannis K, Gkolfakis P, Spithakis G, et al. (2019). Effect of a Preparation of Four Probiotics on Symptoms of Patients with Irritable Bowel Syndrome: Association with Intestinal Bacterial Overgrowth. *Probiotics and Antimicrobial Proteins*, 11(2), 627–634. https://doi.org/10.1007/s12602-018-9401-3
Shah A, Morrison M, Burger T, et al. (2018). Systematic review with meta-analysis: the prevalence of small intestinal bacterial overgrowth in inflammatory bowel disease. *Alimentary Pharmacology & Therapeutics*, 47(2), 169–178. https://doi.org/10.1111/apt.14388

Ready to resolve your SIBO for good? If you recognise your experience in this article — the bloating that returns regardless of what you eat, the fatigue that doesn't respond to better sleep, the brain fog that follows every meal — the next step is understanding what is specifically driving your presentation. Book a SYNC Diagnostic Session: a 90-minute comprehensive assessment that maps the root causes of your gut symptoms and builds a precise, phased protocol for lasting resolution. [Book your consultation →](https://calendly.com/ritasoaresnutrition) For a structured, clinically supervised approach to SIBO and gut restoration, explore the [Foundation Protocol™**](https://www.ritasoareshealth.com/gut-health-reset-program) — a 4-month programme designed for people who are done treating symptoms without addressing their cause.

*Rita Soares is a functional medicine nutritionist based in Lisbon, Portugal, specialising in gut health, longevity, and hormonal balance. Member of the Portuguese Order of Nutritionists (No. 2604N) and the Institute for Functional Medicine (IFM). ritasoareshealth.com*